Is CSTL a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Castle Biosciences Inc (CSTL) is 10.85 USD. With the latest stock price at 19.29 USD, the upside of Castle Biosciences Inc based on DCF is -43.7%. This means that CSTL is a sell according to the DCF valuation model.
Range | Selected | |
WACC / Discount Rate | 5.8% - 8.0% | 6.9% |
Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
Fair Price | 7.86 - 29.22 | 10.85 |
Upside | -59.2% - 51.5% | -43.7% |